Awarded
Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV
Original language: Portuguese
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Contract value
- no value published
- Bids received
- 1
- Published
- 26 Oct 2026
- Awarded
- 16 Oct 2026
- Contract start
- 16 Oct 2026
- Contract end
- 29 Oct 2027estimated
- Region
- Região de Coimbra
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| RISDIPLAM 5 MG COMP | Unidade Local de Saúde de Coimbra, EPE | ROCHE Farmacêutica Química, LDA | €741,405 | 27 Oct 2026 |
| Tafasitamab 200 mg Pó conc sol inj Fr IV | Unidade Local de Saúde de Coimbra, EPE | Cencora 3Pl Portugal, S.A. | €126,324 | 26 Oct 2026 |
| Pemigatinib 13.5 mg Comp | Unidade Local de Saúde de Coimbra, EPE | Cencora 3Pl Portugal, S.A. | €136,627 | 26 Oct 2026 |
| Tocilizumab 162 mg/0.9 ml Sol inj Caneta 0.9 ml SC | Unidade Local de Saúde de Coimbra, EPE | ROCHE Farmacêutica Química, LDA | €473,664 | 26 Oct 2026 |
| ZANUBRUTINIB 160 MG COMP | Unidade Local de Saúde de Coimbra, EPE | Cencora 3Pl Portugal, S.A. | €454,109 | 23 Oct 2026 |
| VELMANASE ALFA 10 MG PÓ SOL INJ FR IV | Unidade Local de Saúde de Coimbra, EPE | Celltrion Portugal, Unipessoal Lda | €334,768 | 23 Oct 2026 |